These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12355014)

  • 1. Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations.
    Gonen O; Moriarty DM; Li BS; Babb JS; He J; Listerud J; Jacobs D; Markowitz CE; Grossman RI
    Radiology; 2002 Oct; 225(1):261-8. PubMed ID: 12355014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
    Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-brain N-acetylaspartate concentration: correlation with T2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis.
    Bonneville F; Moriarty DM; Li BS; Babb JS; Grossman RI; Gonen O
    AJNR Am J Neuroradiol; 2002 Mar; 23(3):371-5. PubMed ID: 11901002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis.
    Inglese M; Ge Y; Filippi M; Falini A; Grossman RI; Gonen O
    Neuroimage; 2004 Apr; 21(4):1825-9. PubMed ID: 15050603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
    Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B
    Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of three whole-brain N-acetylaspartate decline cohorts in relapsing-remitting multiple sclerosis.
    Gonen O; Oberndorfer TA; Inglese M; Babb JS; Herbert J; Grossman RI
    AJNR Am J Neuroradiol; 2007 Feb; 28(2):267-71. PubMed ID: 17296992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis.
    Rigotti DJ; Inglese M; Kirov II; Gorynski E; Perry NN; Babb JS; Herbert J; Grossman RI; Gonen O
    Neurology; 2012 May; 78(18):1383-9. PubMed ID: 22517095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.
    Gadea M; Martínez-Bisbal MC; Marti-Bonmatí L; Espert R; Casanova B; Coret F; Celda B
    Brain; 2004 Jan; 127(Pt 1):89-98. PubMed ID: 14506072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
    Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
    Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
    Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total brain N-acetylaspartate: a new measure of disease load in MS.
    Gonen O; Catalaa I; Babb JS; Ge Y; Mannon LJ; Kolson DL; Grossman RI
    Neurology; 2000 Jan; 54(1):15-9. PubMed ID: 10636119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.
    Achtnichts L; Gonen O; Rigotti DJ; Babb JS; Naegelin Y; Penner IK; Bendfeldt K; Hirsch J; Amann M; Kappos L; Gass A
    Eur J Radiol; 2013 Dec; 82(12):e848-52. PubMed ID: 24041438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.
    Falini A; Bozzali M; Magnani G; Pero G; Gambini A; Benedetti B; Mossini R; Franceschi M; Comi G; Scotti G; Filippi M
    Neuroimage; 2005 Jul; 26(4):1159-63. PubMed ID: 15878675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal cell injury precedes brain atrophy in multiple sclerosis.
    Ge Y; Gonen O; Inglese M; Babb JS; Markowitz CE; Grossman RI
    Neurology; 2004 Feb; 62(4):624-7. PubMed ID: 14981182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
    Oreja-Guevara C; Charil A; Caputo D; Cavarretta R; Sormani MP; Filippi M
    Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment.
    Rigotti DJ; Gass A; Achtnichts L; Inglese M; Babb JS; Naegelin Y; Hirsch J; Amann M; Kappos L; Gonen O
    Mult Scler; 2012 Jan; 18(1):98-107. PubMed ID: 21921070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T.
    Wang S; Poptani H; Woo JH; Desiderio LM; Elman LB; McCluskey LF; Krejza J; Melhem ER
    Radiology; 2006 Jun; 239(3):831-8. PubMed ID: 16641339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.
    Ruiz-Peña JL; Piñero P; Sellers G; Argente J; Casado A; Foronda J; Uclés A; Izquierdo G
    BMC Neurol; 2004 Jun; 4():8. PubMed ID: 15191618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry.
    Jasperse B; Jakobs C; Eikelenboom MJ; Dijkstra CD; Uitdehaag BM; Barkhof F; Polman CH; Teunissen CE
    J Neurol; 2007 May; 254(5):631-7. PubMed ID: 17415509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.